Oxford Covid-19 vaccine shows 70% efficacy in phase 2/3 trials 11/23/2020 Health News, Oxford University’s AstraZeneca vaccine candidate, AZD1222, against coronavirus disease (Covid-19) has shown 70% efficacy on...